Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Sweden / NCT04585516
Active, not recruiting Observational

Diagnostic Usefulness of Different Types of Gastrointestinal Endoscopic Investigations.

NCT04585516 · tracked via the Priya Life Science Sweden tracker
Sponsor
Region Örebro County
Phase
Observational
Started
2020-01-01
Last updated
2020-10-14

Condition(s) studied

Colo-rectal CancerGastrointestinal Disease

Investigational drug(s) / intervention(s)

endoscopy

endoscopy: Colonoscopy or gastroscopy

Study summary

The number of endoscopies performed varies greatly between different countries and does not reflect variations in disease incidents. The costs of unnecessary endoscopies are significant and with a better selection of which patients need to be examined with endoscopy, resources could be saved in healthcare, and a better triage would mean that malignancies and other more serious conditions do not have to wait. An example of unnecessary endoscopy is a colonoscopy in patients with irritable bowel syndrome or gastroscopy in patients with functional dyspepsia.

The purpose of the project is, among other things:

* What diagnostic benefit have gastroscopy, colonoscopy, capsule endoscopy and double balloon enteroscopy for different indications in different age groups?
* What are the risks of this type of examination?
* Can patients be better selected based on symptoms, psychometric data or laboratory findings to reduce the number of unnecessary examinations and prioritize those that should be scooped up first?
* Can changed calling methods reduce the number of late cancellations and rebookings and missed patients?

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: All patients who underwent a diagnostic diagnostic procedure at the endoscopy unit at the University Hospital Örebro. Exclusion Criteria: Patients \<18 years

Primary outcome measure(s)

  • All confirmed colorectal cancer cases that were diagnosed via colonoscopy. — between September 2016 and December 2018
    The proportion of patients that was admitted to the department of surgery with confirmed colorectal cancer, diagnosed according to the standardized course of care for colorectal cancer.
  • Proportion of patients that was diagnosed with colorectal cancer. with colorectal cancer — between September 2016 and December 2018
    All patients that were admitted to the endoscopy unit according to the standardized course of care for colorectal cancer.
  • Presence of upper GI pathology — between Jan 2019-April 2020
    The proportion of upper GI pathology in all patients \<50 years who were admitted for a gastroscopy

Trial sites (1)

FacilityCityRegionStatus
University hospital Örebro Egion Rebro Ounty

More Region Örebro County trials in Sweden

Digitally Distributed Yoga for Women Treated for Breast Cancer Active, not recruiting
Structured Physical Training with and Without Cognitive Support for Adults with ADHD Active, not recruiting
Improving Participation of Autistic Children and Adolescents in the Habilitation Process Enrolling by invitation
Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project Active, not recruiting
Internet Treatment for Patients With Obesity Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04585516 on ClinicalTrials.gov ↗ ← All trials in Sweden